Abstract
Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) focuses on the integrated care of chronic diseases. Area 5 (Care Pathways) was initiated using chronic respiratory diseases as a model. The chronic respiratory disease action plan includes (1) AIRWAYS integrated care pathways (ICPs), (2) the joint initiative between the Reference site MACVIA-LR (Contre les MAladies Chroniques pour un VIeillissement Actif) and ARIA (Allergic Rhinitis and its Impact on Asthma), (3) Commitments for Action to the European Innovation Partnership on Active and Healthy Ageing and the AIRWAYS ICPs network. It is deployed in collaboration with the World Health Organization Global Alliance against Chronic Respiratory Diseases (GARD). The European Innovation Partnership on Active and Healthy Ageing has proposed a 5-step framework for developing an individual scaling up strategy: (1) what to scale up: (1-a) databases of good practices, (1-b) assessment of viability of the scaling up of good practices, (1-c) classification of good practices for local replication and (2) how to scale up: (2-a) facilitating partnerships for scaling up, (2-b) implementation of key success factors and lessons learnt, including emerging technologies for individualised and predictive medicine. This strategy has already been applied to the chronic respiratory disease action plan of the European Innovation Partnership on Active and Healthy Ageing.
Original language | English |
---|---|
Article number | 29 |
Pages (from-to) | 1-18 |
Number of pages | 18 |
Journal | Clinical and Translational Allergy |
Volume | 6 |
DOIs | |
Publication status | Published - 29 Jul 2016 |
Keywords
- EIP on AHA
- European Innovation Partnership on Active and Healthy Ageing
- Chronic respiratory diseases
- AIRWAYS ICPs
- MACVIA
- ARIA
- Scaling up
Access to Document
- 10.1186/s13601-016-0116-9Licence: CC BY
- Final Published Version
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Final published version, 1.25 MBLicence: CC BY
Fingerprint
Dive into the research topics of 'Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Clinical and Translational Allergy, Vol. 6, 29, 29.07.2016, p. 1-18.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
AU - Bousquet, J
AU - Farrell, J
AU - Crooks, G
AU - Hellings, P
AU - Bel, E H
AU - Bewick, M
AU - Chavannes, N H
AU - de Sousa, J Correia
AU - Cruz, A A
AU - Haahtela, T
AU - Joos, G
AU - Khaltaev, N
AU - Malva, J
AU - Muraro, A
AU - Nogues, M
AU - Palkonen, S
AU - Pedersen, S
AU - Robalo-Cordeiro, C
AU - Samolinski, B
AU - Strandberg, T
AU - Valiulis, A
AU - Yorgancioglu, A
AU - Zuberbier, T
AU - Bedbrook, A
AU - Aberer, W
AU - Adachi, M
AU - Agusti, A
AU - Akdis, C A
AU - Akdis, M
AU - Ankri, J
AU - Alonso, A
AU - Annesi-Maesano, I
AU - Ansotegui, I J
AU - Anto, J M
AU - Arnavielhe, S
AU - Arshad, H
AU - Bai, C
AU - Baiardini, I
AU - Bachert, C
AU - Baigenzhin, A K
AU - Barbara, C
AU - Bateman, E D
AU - Beghé, B
AU - Kheder, A Ben
AU - Bennoor, K S
AU - Benson, M
AU - Bergmann, K C
AU - Bieber, T
AU - Bindslev-Jensen, C
AU - Bjermer, L
AU - Blain, H
AU - Blasi, F
AU - Boner, A L
AU - Bonini, M
AU - Bonini, S
AU - Bosnic-Anticevitch, S
AU - Boulet, L P
AU - Bourret, R
AU - Bousquet, P J
AU - Braido, F
AU - Briggs, A H
AU - Brightling, C E
AU - Brozek, J
AU - Buhl, R
AU - Burney, P G
AU - Bush, A
AU - Caballero-Fonseca, F
AU - Caimmi, D
AU - Calderon, M A
AU - Calverley, P M
AU - Camargos, P A M
AU - Canonica, G W
AU - Camuzat, T
AU - Carlsen, K H
AU - Carr, W
AU - Carriazo, A
AU - Casale, T
AU - Cepeda Sarabia, A M
AU - Chatzi, L
AU - Chen, Y Z
AU - Chiron, R
AU - Chkhartishvili, E
AU - Chuchalin, A G
AU - Chung, K F
AU - Ciprandi, G
AU - Cirule, I
AU - Cox, L
AU - Costa, D J
AU - Custovic, A
AU - Dahl, R
AU - Dahlen, S E
AU - Darsow, U
AU - De Carlo, G
AU - De Blay, F
AU - Dedeu, T
AU - Deleanu, D
AU - De Manuel Keenoy, E
AU - Demoly, P
AU - Denburg, J A
AU - Devillier, P
AU - Didier, A
AU - Dinh-Xuan, A T
AU - Djukanovic, R
AU - Dokic, D
AU - Douagui, H
AU - Dray, G
AU - Dubakiene, R
AU - Durham, S R
AU - Dykewicz, M S
AU - El-Gamal, Y
AU - Emuzyte, R
AU - Fabbri, L M
AU - Fletcher, M
AU - Fiocchi, A
AU - Fink Wagner, A
AU - Fonseca, J
AU - Fokkens, W J
AU - Forastiere, F
AU - Frith, P
AU - Gaga, M
AU - Gamkrelidze, A
AU - Garces, J
AU - Garcia-Aymerich, J
AU - Gemicioğlu, B
AU - Gereda, J E
AU - González Diaz, S
AU - Gotua, M
AU - Grisle, I
AU - Grouse, L
AU - Gutter, Z
AU - Guzmán, M A
AU - Heaney, L G
AU - Hellquist-Dahl, B
AU - Henderson, D
AU - Hendry, A
AU - Heinrich, J
AU - Heve, D
AU - Horak, F
AU - Hourihane, J O' B
AU - Howarth, P
AU - Humbert, M
AU - Hyland, M E
AU - Illario, M
AU - Ivancevich, J C
AU - Jardim, J R
AU - Jares, E J
AU - Jeandel, C
AU - Jenkins, C
AU - Johnston, S L
AU - Jonquet, O
AU - Julge, K
AU - Jung, K S
AU - Just, J
AU - Kaidashev, I
AU - Khaitov, M R
AU - Kalayci, O
AU - Kalyoncu, A F
AU - Keil, T
AU - Keith, P K
AU - Klimek, L
AU - Koffi N'Goran, B
AU - Kolek, V
AU - Koppelman, G H
AU - Kowalski, M L
AU - Kull, I
AU - Kuna, P
AU - Kvedariene, V
AU - Lambrecht, B
AU - Lau, S
AU - Larenas-Linnemann, D
AU - Laune, D
AU - Le, L T T
AU - Lieberman, P
AU - Lipworth, B.
AU - Li, J
AU - Lodrup Carlsen, K
AU - Louis, R
AU - MacNee, W
AU - Magard, Y
AU - Magnan, A
AU - Mahboub, B
AU - Mair, A
AU - Majer, I
AU - Makela, M J
AU - Manning, P
AU - Mara, S
AU - Marshall, G D
AU - Masjedi, M R
AU - Matignon, P
AU - Maurer, M
AU - Mavale-Manuel, S
AU - Melén, E
AU - Melo-Gomes, E
AU - Meltzer, E O
AU - Menzies-Gow, A
AU - Merk, H
AU - Michel, J P
AU - Miculinic, N
AU - Mihaltan, F
AU - Milenkovic, B
AU - Mohammad, G M Y
AU - Molimard, M
AU - Momas, I
AU - Montilla-Santana, A
AU - Morais-Almeida, M
AU - Morgan, M
AU - Mösges, R
AU - Mullol, J
AU - Nafti, S
AU - Namazova-Baranova, L
AU - Naclerio, R
AU - Neou, A
AU - Neffen, H
AU - Nekam, K
AU - Niggemann, B
AU - Ninot, G
AU - Nyembue, T D
AU - O'Hehir, R E
AU - Ohta, K
AU - Okamoto, Y
AU - Okubo, K
AU - Ouedraogo, S
AU - Paggiaro, P
AU - Pali-Schöll, I
AU - Panzner, P
AU - Papadopoulos, N
AU - Papi, A
AU - Park, H S
AU - Passalacqua, G
AU - Pavord, I
AU - Pawankar, R
AU - Pengelly, R
AU - Pfaar, O
AU - Picard, R
AU - Pigearias, B
AU - Pin, I
AU - Plavec, D
AU - Poethig, D
AU - Pohl, W
AU - Popov, T A
AU - Portejoie, F
AU - Potter, P
AU - Postma, D
AU - Price, D
AU - Rabe, K F
AU - Raciborski, F
AU - Radier Pontal, F
AU - Repka-Ramirez, S
AU - Reitamo, S
AU - Rennard, S
AU - Rodenas, F
AU - Roberts, J
AU - Roca, J
AU - Rodriguez Mañas, L
AU - Rolland, C
AU - Roman Rodriguez, M
AU - Romano, A
AU - Rosado-Pinto, J
AU - Rosario, N
AU - Rosenwasser, L
AU - Rottem, M
AU - Ryan, D
AU - Sanchez-Borges, M
AU - Scadding, G K
AU - Schunemann, H J
AU - Serrano, E
AU - Schmid-Grendelmeier, P
AU - Schulz, H
AU - Sheikh, A
AU - Shields, M
AU - Siafakas, N
AU - Sibille, Y
AU - Similowski, T
AU - Simons, F E R
AU - Sisul, J C
AU - Skrindo, I
AU - Smit, H A
AU - Solé, D
AU - Sooronbaev, T
AU - Spranger, O
AU - Stelmach, R
AU - Sterk, P J
AU - Sunyer, J
AU - Thijs, C
AU - To, T
AU - Todo-Bom, A
AU - Triggiani, M
AU - Valenta, R
AU - Valero, A L
AU - Valia, E
AU - Valovirta, E
AU - Van Ganse, E
AU - van Hage, M
AU - Vandenplas, O
AU - Vasankari, T
AU - Vellas, B
AU - Vestbo, J
AU - Vezzani, G
AU - Vichyanond, P
AU - Viegi, G
AU - Vogelmeier, C
AU - Vontetsianos, T
AU - Wagenmann, M
AU - Wallaert, B
AU - Walker, S
AU - Wang, D Y
AU - Wahn, U
AU - Wickman, M
AU - Williams, D M
AU - Williams, S
AU - Wright, J
AU - Yawn, B P
AU - Yiallouros, P K
AU - Yusuf, O M
AU - Zaidi, A
AU - Zar, H J
AU - Zernotti, M E
AU - Zhang, L
AU - Zhong, N
AU - Zidarn, M
AU - Mercier, J
N1 - No Funding.
PY - 2016/7/29
Y1 - 2016/7/29
N2 - Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) focuses on the integrated care of chronic diseases. Area 5 (Care Pathways) was initiated using chronic respiratory diseases as a model. The chronic respiratory disease action plan includes (1) AIRWAYS integrated care pathways (ICPs), (2) the joint initiative between the Reference site MACVIA-LR (Contre les MAladies Chroniques pour un VIeillissement Actif) and ARIA (Allergic Rhinitis and its Impact on Asthma), (3) Commitments for Action to the European Innovation Partnership on Active and Healthy Ageing and the AIRWAYS ICPs network. It is deployed in collaboration with the World Health Organization Global Alliance against Chronic Respiratory Diseases (GARD). The European Innovation Partnership on Active and Healthy Ageing has proposed a 5-step framework for developing an individual scaling up strategy: (1) what to scale up: (1-a) databases of good practices, (1-b) assessment of viability of the scaling up of good practices, (1-c) classification of good practices for local replication and (2) how to scale up: (2-a) facilitating partnerships for scaling up, (2-b) implementation of key success factors and lessons learnt, including emerging technologies for individualised and predictive medicine. This strategy has already been applied to the chronic respiratory disease action plan of the European Innovation Partnership on Active and Healthy Ageing.
AB - Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) focuses on the integrated care of chronic diseases. Area 5 (Care Pathways) was initiated using chronic respiratory diseases as a model. The chronic respiratory disease action plan includes (1) AIRWAYS integrated care pathways (ICPs), (2) the joint initiative between the Reference site MACVIA-LR (Contre les MAladies Chroniques pour un VIeillissement Actif) and ARIA (Allergic Rhinitis and its Impact on Asthma), (3) Commitments for Action to the European Innovation Partnership on Active and Healthy Ageing and the AIRWAYS ICPs network. It is deployed in collaboration with the World Health Organization Global Alliance against Chronic Respiratory Diseases (GARD). The European Innovation Partnership on Active and Healthy Ageing has proposed a 5-step framework for developing an individual scaling up strategy: (1) what to scale up: (1-a) databases of good practices, (1-b) assessment of viability of the scaling up of good practices, (1-c) classification of good practices for local replication and (2) how to scale up: (2-a) facilitating partnerships for scaling up, (2-b) implementation of key success factors and lessons learnt, including emerging technologies for individualised and predictive medicine. This strategy has already been applied to the chronic respiratory disease action plan of the European Innovation Partnership on Active and Healthy Ageing.
KW - EIP on AHA
KW - European Innovation Partnership on Active and Healthy Ageing
KW - Chronic respiratory diseases
KW - AIRWAYS ICPs
KW - MACVIA
KW - ARIA
KW - Scaling up
U2 - 10.1186/s13601-016-0116-9
DO - 10.1186/s13601-016-0116-9
M3 - Article
C2 - 27478588
SN - 2045-7022
VL - 6
SP - 1
EP - 18
JO - Clinical and Translational Allergy
JF - Clinical and Translational Allergy
M1 - 29
ER -